ArticleProteins2026
MassiveFold Data for CASP16-CAPRI: A Systematic Massive Sampling Experiment.
Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Molecular dockingDigital discovery · 2026Article
- Practical Outcomes From CASP16 for Users in Need of Biomolecular Structure Prediction.Proteins · 2026Review
- Model Quality Assessment for CASP16.Proteins · 2026Article
- Updates to the CASP Infrastructure in 2024.Proteins · 2026Article
- Progress and Bottlenecks for Deep Learning in Computational Structure Biology: CASP Round XVI.Proteins · 2026Article
- Cryo-EM Analysis in CASP16.Proteins · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Massive sampling with AlphaFold2 has become a widely used approach in protein structure prediction. Here we present the MassiveFold CASP16-CAPRI dataset, a systematic, large-scale sampling of both monomeric and multimeric protein targets. By exploiting maximal parallelization, we produced up to 8040 models per target and shared them with the community for collaborative selection and scoring. This collective effort minimizes redundant computation and environmental impact, while granting resource-limited groups - especially those focused on scoring - access to high quality structures. In our analysis, we define an interface-difficulty classification based on DockQ metrics, showing that massive sampling yields the greatest gains on most of the challenging interfaces. Crucially, this classification can be predicted from the median ipTM scores of a routine AF2 run, enabling users to selectively deploy massive sampling only when it is most needed. Combined with a reduction of the massive sampling from 8040 to 2475 predictions, such targeted strategies dramatically cut computation time and resource use with minimal loss of accuracy. Finally, we underscore the persistent challenge of choosing optimal models from massive sampling datasets, emphasizing the need for more robust scoring methods. The MassiveFold datasets, together with AlphaFold ranking scores and CASP and CAPRI assessment metrics, are publicly available at https://github.com/GBLille/CASP16-CAPRI_MassiveFold_Data to accelerate further progress in protein structure prediction and assembly modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.